Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
June 7, 2007

Correlogic Systems and JEOL Sign R&D Agreement for Clinical Application of Mass Spec

  • Correlogic Systems and JEOL signed a research and development agreement focused on further enhancing the performance of mass spectrometry in a clinical setting. Correlogic and JEOL have collaborated for more than a year under an informal agreement and have made great strides in the continuing validation of various mass spectrometer-based assays, according to the companies.

    “Over the past year, we have had a very close and productive research collaboration with JEOL,” said Peter J. Levine, president and CEO of Correlogic Systems. “This agreement formalizes our link.”

  • You’re all set! Thank you for subscribing to GEN Highlights.